Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,657 Endocrine
clinical trials

Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Obesity Clinical Trial
Insulin Resistance and Reward
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Texas Kidney Institute (Neprhotex Research Group)
mi
from
Dallas, TX
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada-Horizon Ridge
mi
from
Henderson, NV
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Promedica Flower Hospital
mi
from
Sylvania, OH
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility 1
mi
from
Boston, MA
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility # 1
mi
from
Darlinghurst,
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility 1
mi
from
San Diego, CA
Click here to add this to my saved trials
Secondary Hyperparathyroidism-Chronic Kidney Disease Clinical Trial
Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Secondary Hyperparathyroidism-Chronic Kidney Disease Clinical Trial
Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Overweight and Obesity Clinical Trial
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and With and Without Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
SAMCRC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hypogonadism, Male Clinical Trial
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status: Enrolling, Phase III
Updated: 12/31/1969
Rapha Institute For Clinical Research
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Orange, CA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology, Other Clinical Trial
Scanadu Urine Device Validation Study Protocol
Status: Enrolling
Updated: 11/21/2016
West Coast Research, LLC
mi
from
Mountain View, CA
Click here to add this to my saved trials
Indeterminate Thyroid Cytology Clinical Trial
Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules
Status: Enrolling
Updated: 10/24/2017
Lee Moffit Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Metabolic Syndrome X Clinical Trial
Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects
Status: Enrolling, Phase I
Updated: 10/10/2017
Altman Clinical and Translational Research Institute (ACTRI)
mi
from
San Diego, CA
Click here to add this to my saved trials
Metastatic Anaplastic Thyroid Cancer Clinical Trial
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Endocrinology Clinical Trial
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Endocrinology, Psychiatry / Psychology, Reproductive Clinical Trial
Maternal Emotions and Diet in Pregnancy
Status: Enrolling
Updated: 12/31/1969
UCI Medical Center, University of California, Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Insulin Resistance, Diabetes Clinical Trial
Validation of a Novel Screening Test for Maternal Insulin Resistance
Status: Enrolling, Phase
Updated: 12/31/1969
Ashley Salazar
mi
from
Galveston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Oncology, Psychiatry / Psychology Clinical Trial
A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer
Status: Enrolling
Updated: 2/17/2018
Northern Arizona University
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Type 1 Diabetes Mellitus With Hypoglycemia Clinical Trial
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Sweet Hope Research Speciality, Inc.
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
California Medical Research Associates, Inc. (CMRA)
mi
from
Northridge, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
California Kidney Specialists
mi
from
San Dimas, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Northside Endocrinology
mi
from
Spokane, WA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
Status: Enrolling
Updated: 12/31/1969
Plymouth State University
mi
from
Plymouth, NH
Click here to add this to my saved trials
Endocrinology Clinical Trial
Type 2 Diabetes and the Brain in Adolescents
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Health System
mi
from
Jacksonville, FL
Click here to add this to my saved trials
CAH - Congenital Adrenal Hyperplasia Clinical Trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance
Status: Enrolling
Updated: 12/31/1969
CIC Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Determinants of Bone Mineral Density and Metabolic Syndrome in South Asian Indian Men
Status: Enrolling, Phase
Updated: 12/31/1969
Drexel University Nutrition Sciences Research Lab
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Other Clinical Trial
Repeated-dose Safety, Efficacy, PK and PD of CTAP101, IR Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With SHPT, CKD 3-4 and VDI
Status: Enrolling, Phase IV
Updated: 12/31/1969
Research by Design, LLC
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Pharmacology / Toxicology, Other Clinical Trial
BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study
Status: Enrolling, Phase
Updated: 12/31/1969
Stanford University; Division of Pediatric Stem Cell Transplant & Regenerative Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Health System-Tawas City
mi
from
Tawas City, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Bolivar
mi
from
Bolivar, MO
Click here to add this to my saved trials
Cushing Syndrome Clinical Trial
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Cushing Syndrome Clinical Trial
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Endocrinology, Hematology, Neurology, Oncology Clinical Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
Status: Enrolling, Phase
Updated: 12/31/1969
North Carolina Cancer Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
Discovery Clinical Research
mi
from
Plantation, FL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Pompe Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Pompe Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Investigational Site Number 076004
mi
from
São Paulo,
Click here to add this to my saved trials
Endocrinology Clinical Trial
Pompe Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Endocrinology, Neurology, Pharmacology / Toxicology Clinical Trial
International Collaborative Gaucher Group (ICGG) Gaucher Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology, Neurology, Pharmacology / Toxicology Clinical Trial
International Collaborative Gaucher Group (ICGG) Gaucher Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University/St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling, Phase IV
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai Cardiology
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Hypoparathyroidism Clinical Trial
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling, Phase
Updated: 12/31/1969
Brokhin Medical PC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Secondary Hypogonadism Clinical Trial
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Status: Enrolling, Phase III
Updated: 1/16/2014
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Secondary Hypogonadism Clinical Trial
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Status: Enrolling, Phase III
Updated: 1/16/2014
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Hypophosphatasia HPP Clinical Trial
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Hypophosphatasia HPP Clinical Trial
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Medullary Thyroid Cancer Clinical Trial
Expanded Access of Cabozantinib in Medullary Thyroid Cancer
Status: Enrolling
Updated: 11/6/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
mi
from
Bron,
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Alaska Native Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Duke University Medical Center (PICU / NICU)
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Kids Research Institute
mi
from
Randwick,
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Crossville, TN
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Muncie, IN
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Paramount, CA
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Spring, TX
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Stockton, CA
Click here to add this to my saved trials
1 … 26 27 28 29 30 31 32 33 34 35 36 37